M. Farouk et al./Chemical Papers
vii
Fahmy, A. F., Youssef, M. S. K., Halim M. S. A., Hassan, M.
A., & Sauer, J. (1986). Novel synthesis of pyridopyrimidine
diones. Heterocycles, 24, 2201–2213. DOI: 10.3987/r-1986-
08-2201.
Koay, N., & Campeau, L. C. (2011). Efficient preparation of 3-
substituted quinazolinediones directly from anthranilic acids
and isocyanates. Journal of Heterocyclic Chemistry, 48, 473–
478. DOI: 10.1002/jhet.551.
Farouk, M. (2009). Bioactive heterocyclic’s based nanotechnol-
ogy. Synthesis and in-vitro evaluation of new 3-substituted
quinazolinediones. In First International Conference for
NanoTechnology Industries (ICNI 2009), April 5–7, 2009.
Riyadh, Saudi Arabia: King Saud University.
Farouk, M., Alrokayan, S. A., Imran, A., & Abu-Salah, K. M.
(2012). One-pot synthesis and luminescent spectra of 3-allyl
substituted quinazoline-2,4-dione derivatives as allyl capping
agents. Chemical Papers, 66, 75–78. DOI: 10.2478/s11696-
011-0094-2.
Fieser, L. F., & Fieser, M. (1967). Reagents for organic synthesis
(pp. 485–486). New York, NY, USA: Wiley.
Furniss, B. S., Hannaford, A. J., Smith, P. W. G., Tatchell,
A. R., & Vogel, A. I. (1989). Vogel’s textbook of practical
organic chemistry (5th ed.). Harlow, UK: Pearson Education
Limited.
Koller, M., Lingenhoehl, K., Schmutz, M., Vranesic, I. T.,
Kallen, J., Auberson, Y. P., Carcache, D. A., Mattes, H.,
Ofner, S., Orain, D., & Urwyler, S. (2011). Quinazoline-
dione sulfonamides: A novel class of competitive AMPA re-
ceptor antagonists with oral activity. Bioorganic & Medicinal
Chemistry Letters, 21, 3385–3361. DOI: 10.1016/j.bmcl.2011.
04.017.
Li, J., Chen, X., Shi, D., Ma, S., Li„ Zhang, Q., & Tang,
J. (2009).
A new and facile synthesis of quinazoline-
2,4(1H,3H )-diones. Organic Letters, 11, 1193–1196. DOI:
10.1021/ol900093h.
Martyn, D. C., Moore, M. J., & Abell, A. D. (1999). Succinimide
and saccharin-based enzyme-activated inhibitors of serine
proteases. Current Pharmaceutical Design, 5, 405–416.
Neumann, U., & Gu¨tschow, M. (1994). N-(Sulfonyloxy)phthal-
imides and analogs are potent inactivators of serine pro-
teases. Journal of Biological Chemistry, 269, 21561–21567.
Orain, D., Ofner, S., Koller, M., Carcache, D. A., Froestl, W.,
Allgeier, H., Rasetti, V., Nozulak, J., Mattes, H., Solder-
mann, N., Floersheim, P., Desrayaud, S., Kallen, J., Lingen-
hoehl, K., & Urwyler, S. (2012). 6-Amino quinazolinedione
sulfonamides as orally active competitive AMPA receptor
antagonists. Bioorganic & Medicinal Chemistry Letters, 22,
996–999. DOI: 10.1016/j.bmcl.2011.12.009.
Perrin, D. D., & Armarego, W. L. F. (1988). Purification of
laboratory chemicals (3rd ed.). Oxford, UK: Pergamon Press.
Petrov, J. S., & Andreev, G. N. (2005). Synthesis of 2,4(1H,3H )-
quinazolinedione and 3-substituted 2,4(1H,3H )-quianzoline-
diones. Organic Preparations and Procedures International:
The New Journal for Organic Synthesis, 37, 560–565. DOI:
10.1080/00304940509354986.
Gu¨tschow, M. (1999). One-pot reactions of N-(mesyloxy)phthal-
imides with secondary amines to 2-ureidobenzamides, 2-
ureidobenzoic acids, ethyl 2-ureidobenzoates, or isatoic an-
hydrides. The Journal of Organic Chemistry, 64, 5109–5115.
DOI: 10.1021/jo9900634.
Huang, C., Meng, X., Cui, J.,
& Li, Z. (2009). Synthe-
sis of 3-N-sugar-substituted-2,4(1H,3H )-quinazolinediones as
anti-angiogenesis agents. Molecules, 14, 2447–2457. DOI:
10.3390/molecules14072447.
Jain, K. S., Bariwal, J. B., Kathiravan, M. K., Phoujdar, M. S.,
Sahne, R. S., Chauhan, B. S., Shah, A. K., & Yadav, M. R.
(2008). Recent advances in selective α1-adrenoreceptor an-
tagonists as antihypertensive agents. Bioorganic & Medicinal
Chemistry, 16, 4759–4800. DOI: 10.1016/j.bmc.2008.02.091.
Kakuta, H., Koiso, Y., Nagasawa, K., & Hashimoto, Y. (2003a).
Fluorescent bioprobes for visualization of puromycin-sensiti-
Rivero, I. A., Espinoza, K., & Somanathan, R. (2004). Syn-
theses of quinazoline-2,4-dione alkaloids and analogues from
Mexican Zanthoxylum species. Molecules, 9, 609–616. DOI:
10.3390/90700609.
ve aminopeptidase in living cells. Bioorganic
& Medi-
cal Chemistry Letters, 13, 83–86. DOI: 10.1016/s0960-
894x(02)00845-4.
Kakuta, H., Tanatani, A., Nagasawa, K., & Hashimoto, Y.
(2003b). Specific nonpeptide inhibitors of puromycin-sensiti-
ve aminopeptidase with a 2,4(1H,3H )-quinazolinedione skele-
tone. Chemical and Pharmaceutical Bulletin, 51, 1273–1282.
DOI: 10.1248/cpb.51.1273.
Rivero, I. A., Guerrero, L., Espinoza, K. A., Meza, M. C.,
&
Rodríguez, J. R. (2009). Alkylation of 2,4-(1H,3H )-
quinazolinediones with dialkyl carbonates under microwave
irradiations. Molecules, 14, 1860–1868. DOI: 10.3390/
molecules14051860.
Katritzky, A. R., & Rees, C. W. (1984). Comprehensive hete-
rocyclic chemistry: The structure, reactions, synthesis and
uses of heterocyclic compounds (Vol. 3). Oxford, UK: Perg-
amon Press.
Kirincich, S. J., Xiang, J., Green, N., Tam, S., Yang, H. Y.,
Shim, J., Shen, M. W. H., Clark, J. D., & McKew, J. C.
(2009). Benzhydrylquinazolinediones: Novel cytosolic phos-
pholipase A2α ginhibitors with improved physicochemical
properties. Bioorganic & Medicinal Chemistry, 17, 4383–
4405. DOI: 10.1016/j.bmc.2009.05.027.
Kerrigan, J. E., Walters, M. C., Forrester, K. J., Crow-
der, J. B., & Christopher, L. J. (2000). 6-Acylamino-2-
[(alkylsulfonyl)oxy]-1H-isoindole-1,3-dione mechanism-based
inhibitors of human leukocyte elastase. Bioorganic & Medic-
inal Chemistry Letters, 10, 27–30. DOI: 10.1016/s0960-
894x(99)00588-0.
Sheradsky, T., & Itzhak, N. (1986). Reaction of carbanions
with N-tosyloxyphthalimide. Formation of 3,3-disubstituted
quinoline-2,4-diones. Journal of the Chemical Society, Per-
kin Transactions 1, 1986, 13–16. DOI: 10.1039/p19860000013.
Shiau, C. Y., Chern, J. W., Liu, K. C., Chan, C. H., Yen, M.
H., Cheng, M. C., & Wang, Y. (1990). Studies on quinazoli-
nones. 2. Synthesis of 2-(4-benzylpiperazin-1-ylmethyl)-2,3-
dihydro-5H-oxazolo[2,3-6]quinazolin-5-one and -2,3-dihydro-
5H-thiazolo[2,3-b]quinazolin-5-one. Journal of Heterocyclic
Chemistry, 27, 1467–1472. DOI: 10.1002/jhet.5570270552.
Vagnoni, L. M., Gronostaj, M., & Kerrigan, J. E. (2001). 6-
Acylamino-2-(ethylsulfonyl)oxy]-1H-isoindole-1,3-diones me-
chanism-based inhibitors of human leukocyte elastase and
cathepsin G: effect of chirality in the 6-acylamino sub-
stituent on inhibitory potency and selectivity. Bioorganic
& Medicinal Chemistry, 9, 637–645. DOI: 10.1016/s0968-
0896(00)00281-9.